Price: $ 1295
BMI View: Despite the transfer of the financial burden of healthcare from the state to the patient going against the aim of most developed-state governments to provide social welfare, BMI believes the success of the measures in reducing public expenditure on drugs in Spain's pharmacy sector will mean the Spanish government implements more policies to reduce its contribution towards the cost of medicines. Furthermore, it is our view that ongoing public hospital debt issues will lead to the government enforcing further price erosion mechanisms on medicines in order to contain costs. Headline Expenditure Projections ? Pharmaceuticals: EUR24.99bn (US$31.74bn) in 2012 to EUR24.08bn (US$32.03bn) in 2013. ? Healthcare: EUR99.62bn (US$126.51bn) in 2012 to EUR99.09bn (US$131.79bn) in 2013; -0.5% in ...
Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/282014.html
No comments:
Post a Comment